Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
49.05
+0.59 (1.22%)
Aug 13, 2025, 4:00 PM - Market closed
PRAX Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for PRAX stock ranges from a low of $28 to a high of $170. The average analyst price target of $102 forecasts a 107.95% increase in the stock price over the next year.
Price Target: $102.00 (+107.95%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 6 | 6 |
| Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $105 → $115 | Strong Buy | Maintains | $105 → $115 | +134.45% | Aug 5, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +63.10% | Jul 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +114.07% | Jul 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $97 → $115 | Buy | Maintains | $97 → $115 | +134.45% | Jul 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +63.10% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
435.82K
from 8.55M
Decreased by -94.90%
Revenue Next Year
15.98M
from 435.82K
Increased by 3,567.38%
EPS This Year
-13.24
from -10.21
EPS Next Year
-12.37
from -13.24
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.2M | 162.8M | 207.6M | ||
| Avg | 435,815 | 16.0M | 61.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -63.2% | 37,243.8% | 1,198.8% | ||
| Avg | -94.9% | 3,567.4% | 287.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -11.64 | -3.89 | -4.15 | ||
| Avg | -13.24 | -12.37 | -11.37 | ||
| Low | -15.38 | -18.98 | -17.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.